Header Logo

Connection

Blaine Mooers to Oncogene Proteins, Fusion

Back to Details
This is a "connection" page, showing publications Blaine Mooers has written about Oncogene Proteins, Fusion.
Blaine Mooers
Connection Strength
0.186
Oncogene Proteins, Fusion
  1. Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer. Ann Oncol. 2021 06; 32(6):817-819.
    View in: PubMed
    Score: 0.186
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.